Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Commentary

C

Couch in Crisis

E

Early Career Psychiatry

H

History of Psychiatry

R

Residents Corner

Trending on Psychiatric Times

FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder

Using Psychotherapy for the Prevention of Relapse in Schizophrenia

Positive Phase 2 Topline Results: Remlifanserin for the Treatment of Alzheimer Disease Psychosis

Searching for a New TMS Target in Schizophrenia, With Andrew Pines, MD

The Adolescent Brain and Schizophrenia: What Research Reveals About Pruning, Dopamine, and Myelin